Kiora Pharmaceuticals (KPRX) Other Operating Expenses (2020 - 2026)

Kiora Pharmaceuticals (KPRX) has reported Other Operating Expenses for 7 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses rose 19.46% year-over-year to -$1.2 million; the trailing twelve-month figure through Jun 2026 stood at -$1.8 million (up 35.21% YoY), and the FY2024 full-year result was -$3859.0, up 86.4% from the prior year.
• Other Operating Expenses slipped to -$1.2 million in Q2 2026 per KPRX's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $4.1 million in Q4 2025 and bottomed at -$3.4 million in Q3 2025.
• Historically, Other Operating Expenses has averaged -$316984.6 across 5 years, with a median of -$84902.0 in 2022.
• The widest YoY moves for Other Operating Expenses: up 722.84% in 2025, down 9422.41% in 2025.
• Over 5 years, Other Operating Expenses stood at -$600137.0 in 2022, then sank by 215.65% to -$1.9 million in 2023, then surged by 126.3% to $498212.0 in 2024, then jumped by 722.84% to $4.1 million in 2025, then sank by 130.41% to -$1.2 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$1.2 million, -$1.2 million, and $4.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.